Effective venetoclax-based treatment in relapsed/refractory multiple myeloma patients with translocation t(6;14)

• Main Authors: Andrea Ceglédi (Author), Zoltán Csukly (Author), Mónika Fekete (Author), András Kozma (Author), Zsuzsanna Szemlaky (Author), Hajnalka Andrikovics (Author), Gábor Mikala (Author)
• Format: Book
• Published: Frontiers Media S.A., 2023-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Introduction: The selective Bcl-2 inhibitor venetoclax has shown promising therapeutic potential in multiple myeloma, particularly in cases associated with t(11;14) IGH::CCND1 translocation. However, the efficacy of venetoclax in myeloma patients with the t(6;14) IGH::CCND3 translocation remains les...